608 related articles for article (PubMed ID: 9244390)
41. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
[TBL] [Abstract][Full Text] [Related]
42. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
43. [Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor].
Larionova NI; Gladysheva IP; Tikhonova TV; Kazanskaia NF
Biokhimiia; 1993 Aug; 58(9):1437-44. PubMed ID: 8218567
[TBL] [Abstract][Full Text] [Related]
44. A simple method to determine trypsin and chymotrypsin inhibitory activity.
Yakoby N; Raskin I
J Biochem Biophys Methods; 2004 Jun; 59(3):241-51. PubMed ID: 15165755
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
[TBL] [Abstract][Full Text] [Related]
46. Polycationic peptides as inhibitors of mast cell serine proteases.
Lundequist A; Juliano MA; Juliano L; Pejler G
Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
[TBL] [Abstract][Full Text] [Related]
47. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D
J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562
[TBL] [Abstract][Full Text] [Related]
48. A rapid purification method for soybean Bowman-Birk protease inhibitor using hydrophobic-interaction chromatography.
Yeboah NA; Arahira M; Udaka K; Fukazawa C
Protein Expr Purif; 1996 May; 7(3):309-14. PubMed ID: 8860657
[TBL] [Abstract][Full Text] [Related]
49. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.
Clemente A; Moreno FJ; Marín-Manzano Mdel C; Jiménez E; Domoney C
Mol Nutr Food Res; 2010 Mar; 54(3):396-405. PubMed ID: 19885848
[TBL] [Abstract][Full Text] [Related]
50. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.
Doggrell SA; Wanstall JC
Cardiovasc Res; 2004 Mar; 61(4):653-62. PubMed ID: 14985062
[TBL] [Abstract][Full Text] [Related]
51. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
Addington AK; Johnson DA
Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
[TBL] [Abstract][Full Text] [Related]
52. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
[TBL] [Abstract][Full Text] [Related]
53. Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor.
Malykh EV; Larionova NI
Biochemistry (Mosc); 2002 Dec; 67(12):1383-7. PubMed ID: 12600268
[TBL] [Abstract][Full Text] [Related]
54. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut.
Miller HR; Pemberton AD
Immunology; 2002 Apr; 105(4):375-90. PubMed ID: 11985658
[TBL] [Abstract][Full Text] [Related]
55. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
56. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
57. Attenuation of skeletal muscle atrophy via protease inhibition.
Morris CA; Morris LD; Kennedy AR; Sweeney HL
J Appl Physiol (1985); 2005 Nov; 99(5):1719-27. PubMed ID: 15976355
[TBL] [Abstract][Full Text] [Related]
58. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
Selwood T; Elrod KC; Schechter NM
Biol Chem; 2003 Dec; 384(12):1605-11. PubMed ID: 14719803
[TBL] [Abstract][Full Text] [Related]
59. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
60. Tryptase in rat mast cells: properties and inhibition by various inhibitors in comparison with chymase.
Muramatu M; Itoh T; Takei M; Endo K
Biol Chem Hoppe Seyler; 1988 Jul; 369(7):617-25. PubMed ID: 3066368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
